Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: Studies in PON1-knockout mice

Free Radical Biology and Medicine

Volumn 34, Issue 6, 2003, Pages 774-784

  Rozenberg, Orit ^a   Rosenblat, Mira ^a   Coleman, Raymond ^a   Shih, Diana M ^b   Aviram, Michael ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Atherosclerosis; Free radicals; Macrophages; Oxidative stress; Oxidized LDL; Paraoxonase; PON1 knockout mice

Indexed keywords

ARYLDIALKYLPHOSPHATASE; GLUTATHIONE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; PEROXIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME DEFICIENCY; LIPID PEROXIDATION; MACROPHAGE; MALE; MOUSE; MULTIGENE FAMILY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0037443799     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(02)01429-6     Document Type: Article

References (48)

1. Steinberg D., Lewis A. Oxidative modification of LDL and atherogenesis. Circulation. 95:1997;1062-1071.
2. Witztum J.L. The oxidation hypothesis of atherosclerosis. Lancet. 344:1994;793-795.
3. Aviram M. Review of human studies on oxidative damage and antioxidant protection related to cardiovascular diseases. Free Radic. Res. 33:(Suppl.):2000;S85-S97.
4. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J. Biol. Chem. 272:1997;20963-20966.
5. Maor I., Kaplan M., Hayek T., Vaya J., Hoffman A., Aviram M. Oxidized monocyte-derived macrophages in aortic atherosclerotic lesion from apolipoprotein E-deficient mice and from human carotid artery contain lipid peroxides and oxysterols. Biochem. Biophys. Res. Commun. 269:2000;775-780.
6. Rosenblat M., Aviram M. Oxysterol-induced activation of macrophage NADPH-oxidase enhances cell-mediated oxidation of LDL in the atherosclerotic apolipoprotein E deficient mouse inhibitory role for vitamin E . Atherosclerosis. 160:2002;69-80.
7. Fuhrman B., Oiknine J., Aviram M. Iron induces lipid peroxidation in cultured macrophages, increases their ability to oxidatively modify LDL, and affects their secretory properties. Atherosclerosis. 111:1994;65-78.
8. Berliner J.A., Heinecke J.W. The role of oxidized lipoproteins in atherogenesis. Free Radic. Biol. Med. 20:1996;707-727.
9. Fuhrman B., Volkova N., Aviram M. Oxidative stress increases the expression of the CD36 scavenger receptor and the cellular uptake of oxidized low-density lipoprotein in macrophages from atherosclerotic mice protective role of antioxidants and of paraoxonase . Atherosclerosis. 161:2002;307-316.
10. Tward A., Xia Y.R., Wang X.P., Shi Y.S., Park C., Castellani L.W., Lusis A.J., Shih D.M. Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice. Circulation. 106:2002;484-490.
11. Durrington P.N., Mackness B., Mackness M.I. Paraoxonase and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 21:2001;473-480.
12. Mackness M.I., Durrington P.N., Mackness B. How high-density lipoprotein protects against the effects of lipid peroxidation. Curr. Opin. Lipidol. 11:2000;383-388.
13. Aviram M. Does paraoxonase play a role in susceptibility to cardiovascular disease? Mol. Med. Today. 5:1999;381-386.
14. Aviram M., Billecke S., Sorenson R., Bisgaier C., Newton R., Rosenblat M., Erogul J., Hsu C., Dunlop C., La Du B.N. Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities selective action of human paraoxonase allozymes Q and R . Arterioscler. Thromb. Vasc. Biol. 18:1998;1617-1624.
15. Navab M., Berliner J.A., Watson A.D., Hama S.Y., Territo M.C., Lusis A.J., Shih D.M., Van Lenten B.J., Frank J.S., Demer L.L., Edwards P.A., Fogelman A.M. The Yin and Yang of oxidation in the development of the fatty streak. Arterioscler. Thromb. Vasc. Biol. 16:1996;831-842.
16. Aviram M., Rosenblat M., Bisgaier C.L., Newton R.S., Primo-Parmo S.L., La Du B.N. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J. Clin. Invest. 101:1998;1581-1590.
17. Aviram M., Hardak E., Vaya J., Mahmood S., Milo S., Hoffman A., Billicke S., Draganov D., Rosenblat M. Human serum paraoxonases (PON1) Q and R selectively decrease lipid peroxides in human coronary and carotid atherosclerotic lesions PON1 esterase and peroxidase-like activities . Circulation. 101:2000;2510-2517.
18. Ahmed Z., Ravandi A., Maguire G.F., Emili A., Draganov D., La Du B.N., Kuksis A., Connelly P.W. Apolipoprotein A-I promotes the formation of phosphatidylcholine core aldehydes that are hydrolyzed by paraoxonase (PON-1) during high density lipoprotein oxidation with a peroxynitrite donor. J. Biol. Chem. 276:2001;24473-24481.
19. Ahmed Z., Ravandi A., Maguire G.F., Emili A., Draganov D., La Du B.N., Kuksis A., Connelly P.W. Multiple substrates for paraoxonase-1 during oxidation of phosphatidylcholine by peroxynitrite. Biochem. Biophys. Res. Commun. 290:2002;391-396.
20. Oda M.N., Bielicki J.K., Ho T.T., Berger T., Rubin E.M., Forte T.M. Paraoxonase 1 overexpression in mice and its effect on high-density lipoproteins. Biochem. Biophys. Res. Commun. 290:2002;921-927.
21. Shih D.M., Gu L., Xia Y.R., Navab M., Li W.F., Hama S., Castellani L.W., Furlong C.E., Costa L.G., Fogelman A.M., Lusis A.J. Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis. Nature. 394:1998;284-287.
22. Shih D.M., Xia Y.R., Wang X.P., Miller E., Castellani L.W., Subbanagounder G., Cheroutre H., Faull K.F., Berliner J.A., Witztum J.L., Lusis A.J. Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis. J. Biol. Chem. 275:2000;17527-17535.
23. Shih D.M., Gu L., Hama S., Xia Y.R., Navab M., Fogelman A.M., Lusis A.J. Genetic-dietary regulation of serum paraoxonase expression and its role in atherogenesis in a mouse model. J. Clin. Invest. 97:1996;1630-1639.
24. Primo-Parmo S.L., Sorenson R.C., Teiber J., La Du B.N. The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family. Genomics. 33:1996;498-507.
25. Reddy S.T., Wadleigh D.J., Grijalva V., Ng C., Hama S., Gangopadhyay A., Shih D.M., Lusis A.J., Navab M., Fogelman A.M. Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids. Arterioscler. Thromb. Vasc. Biol. 21:2001;542-547.
26. Draganov D.I., Stetson P.L., Watson C.E., Billecke S.S., La Du B.N. Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation. J. Biol. Chem. 275:2000;33435-33442.
27. Ng C.J., Wadleigh D.J., Gangopadhyay A., Hama S., Grijalva V.R., Navab M., Fogelman A.M., Reddy S.T. Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein. J. Biol. Chem. 276:2001;44444-44449.
28. Gan K.N., Smolen A., Eckerson H.W., La Du B.N. Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities. Drug. Metab. Dispos. 19:1991;100-106.
29. Lowry O.H., Rosebrough N.J., Farr L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
30. El Saadani M., Esterbauer H., El Sayed M., Goher M., Nassar A.Y., Jurgens G. A spectrophotometric assay for lipid peroxides in serum lipoproteins using a commercially available reagent. J. Lipid. Res. 30:1989;627-630.
31. Buege J.A., Aust S.D. Microsomal lipid peroxidation. Methods Enzymol. 52:1978;302-310.
32. Kobzik L., Godleski J.J., Brain J.D. Oxidative metabolism in the alveolar macrophage analysis by flow cytometry . J. Leukoc. Biol. 47:1990;295-303.
33. Tietze F. Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione application to mammalian blood and other tissues . Anal. Biochem. 27:1969;502-522.
34. Levy R., Rotrosen D., Nagauker O., Leto L.T., Malech H.L. Induction of the respiratory burst in HL-60 cells. Correlation of function and protein expression. J. Immunol. 145:1990;2595-2601.
35. Plump A.S., Smith J.D., Hayek T., Aalto-Setala K., Walsh A., Verstuyft J.G., Rubin E.M., Breslow J.L. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 71:1992;343-353.
36. Rosenblat M., Coleman R., Aviram M. Increased macrophage glutathione content reduces cell-mediated oxidation of LDL and atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis. 163:2002;17-28.
37. Nozawa M., Tanizawa K., Kanaoka Y. New chromogenic and fluorogenic substrates for determination of butyrylcholinesterase and arylesterase activities. J. Parmacobiodyn. 3:1980;321-327.
38. Sogorb M.A., Sanchez I., Lopez-Rivadulla M., Cespedes V., Vilanova E. EDTA-resistant and sensitive phosphotriesterase activities associated with albumin and lipoproteins in rabbit serum. Drug Metab. Dispos. 27:1999;53-59.
39. Rosenblat M., Grunfeld O., Hayek T., Aviram M. Serum paraoxonase activity and the extent of lipid peroxidation are not affected by increased levels of human apolipoprotein A-I studies in transgenic mice . Clin. Chem. Lab. Med. 40:2002;9-14.
40. Kaplan M., Aviram M. Retention of oxidized LDL by extracellular matrix proteoglycans leads to its uptake by macrophages an alternative approach to study lipoproteins cellular uptake . Arterioscler. Thromb. Vasc. Biol. 21:2001;386-393.
41. Keller-Weibel G., Yancey P.G., Jerome W.G., Walser T., Mason R.P., Phillips M.C., Rothblat G.H. Crystallization of free cholesterol in model macrophage foam cells. Arterioscler. Thromb. Vasc. Biol. 19:1999;1891-1898.
42. Rosenblat M., Aviram M. Macrophage glutathione content and glutathione peroxidase activity are inversely related to cell-mediated oxidation of LDL. Free Radic. Biol. Med. 24:1998;305-317.
43. Hayek T., Fuhrman B., Vaya J., Rosenblat M., Belinky P., Coleman R., Elis A., Aviram M. Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation. Arterioscler. Thromb. Vasc. Biol. 17:1997;2744-2752.
44. Sorenson R.C., Bisgaier C.L., Aviram M., Hsu C., Billecke S., La Du B.N. Human serum Paraoxonase/Arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids apolipoprotein A-I stabilizes activity . Arterioscler. Thromb. Vasc. Biol. 19:1999;2214-2225.
45. Deakin S., Leviev I., Gomaraschi M., Calabresi L., Franceschini G., James R.W. Enzymatically active paraoxonase-1 is located at the external membrane of producing cells and released by a high affinity, saturable, desorption mechanism. J. Biol. Chem. 277:2002;4301-4308.
46. Schmitz G., Robenek H., Lohmann U., Assmann G. Interaction of high density lipoproteins with cholesteryl ester-laden macrophages biochemical and morphological characterization of cell surface receptor binding, endocytosis and resecretion of high density lipoproteins by macrophages . EMBO J. 4:1985;613-622.
47. Rosenblat, M.; Draganov, D.; Watson, C. E.; Bisgaier, C. L.; La Du, B. N.; Aviram, M. Mouse macrophage paraoxonase 2 (PON2) activity is increased whereas cellular PON3 activity is decreased under oxidative stress. Arterioscler. Thromb. Vasc. Biol. In press; 2003.
48. 2-like activity and lysophosphatidylcholine formation. Arterioscler. Thromb. Vasc. Biol. In press; 2003.